Accelrys, Inc. (NASDAQ:ACCL)

CAPS Rating: 1 out of 5

The Company develops and commercializes software for the aggregation, mining, integration, analysis, simulation, management and interactive reporting of scientific data used by biologists, chemists and materials scientists.

Recs

0
Player Avatar NoahCAPS (< 20) Submitted: 12/5/2006 5:36:48 PM : Outperform Start Price: $6.02 ACCL Score: +28.89

New software release significantly increases the Accelrys solution's value for drug development customers

Featured Broker Partners


Advertisement